Table 3.
Different types of nanocarriers, their advantages and limitations, targeting strategies are briefly discussed in the following tabular format
| Nanocarrier | Typical materials | Targeting mechanism | Advantages | Limitations | References |
|---|---|---|---|---|---|
| Lipid vesicles | Phospholipids, Cholesterol | Pegylation, Antibodies, pH-sensitive lipids | High biocompatibility, biodegradable carry drugs | Poor encapsulation of hydrophobic drugs, physical instability and high production costs | [66] |
| Polymer NPs | PEG, Chitosan | Folic acid, peptides, aptamers, pH-responsive | High stability, control release, versatile surface modification | Potential toxicity of non-biodegradable polymers | [67] |
| Polymer Micelles | Au, FeO, Mesoporous Silica | Antibodies, and aptamers | Excellent for poorly soluble hydrophobic drugs, low CMC confirms stability in blood | Break apart if diluted below CMC in blood, limited drug loading capacity | [68] |
| Solid Lipid NPs | Lipid polymer, Inorganic-polymer | Stimuli-responsive ligand surface modification | High lipophilic drug loading capability and avoids organic solvents stability | Limited drugs loading capacity, risk of drug leakage during storage due to change the structural moiety | [64] |
| Dendrimers | Polylysine, PMMA | Surface-modified targeting ligands, peptides | Well-developed 3D structure, high surface functionality, size control | High production cost, and potential for toxicity | [71] |
| Gold NPs | Amphiphilic block and random copolymers | Target-specific ligands, pH-sensitive, tumor microenvironment | Excellent optical properties for imaging therapy, high stability | Generally poor drug loading capacity, potential long-term cytotoxicity | [95] |
| Magnetic NPs | Natural cell-derived vesicles | Integrins surface receptors, cell-specific modification | External magnetic field used for MRI contrast and medicinal therapy | Potential toxicity tendency requires for protective coating | [96] |
| Cholic acid Micelles | Amphiphilic block copolymers | Target-specific ligands, pH-sensitive, Tumor microenvironment | Hydrophobic drug delivery, Cancer therapy | High production cost, and potential for toxicity | [14] |
| Exosomes | Natural cell-derived vesicles | Surface receptors modification | Targeted drug delivery, | Break apart at below CMC in blood, and limited drug loading capacity | [97] |